LHSC treats first publicly funded Canadian patient with new prostate cancer therapy
January 14, 2025 On Friday, December 27, 2024, Frederick (Fred) Harrison from Swinton Park, Ontario was the first patient in Canada to receive publicly-funded Novartis PLUVICTO TM treatment for prostate cancer at London Health Sciences Centre (LHSC)